申请人:Zhou Ping
公开号:US20080027055A1
公开(公告)日:2008-01-31
The present invention provides a compound of formula I and the use thereof for the therapeutic treatment of disorders relating to or affected by the 5-HT6 receptor.
本发明提供了一种I式化合物及其用途,用于治疗与5-HT6受体相关或受其影响的疾病。